CID 11340891

Retosiban

Structural Information

Molecular Formula
C27H34N4O5
SMILES
CC[C@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](C2=COC(=N2)C)C(=O)N3CCOCC3)C4CC5=CC=CC=C5C4
InChI
InChI=1S/C27H34N4O5/c1-4-16(2)23-25(32)29-22(20-13-18-7-5-6-8-19(18)14-20)26(33)31(23)24(21-15-36-17(3)28-21)27(34)30-9-11-35-12-10-30/h5-8,15-16,20,22-24H,4,9-14H2,1-3H3,(H,29,32)/t16-,22+,23+,24+/m0/s1
InChIKey
PLVGDGRBPMVYPB-FDUHJNRSSA-N
Compound name
(3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl]piperazine-2,5-dione
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

18
References

201
Patents

494.25293 Da
Monoisotopic Mass

2.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 495.26021 218.6
[M+Na]+ 517.24215 227.3
[M+NH4]+ 512.28675 221.6
[M+K]+ 533.21609 228.0
[M-H]- 493.24565 223.5
[M+Na-2H]- 515.22760 218.5
[M]+ 494.25238 220.6
[M]- 494.25348 220.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe